Table 1.

Baseline characteristics of 78 pregnant women who received a second dose and 84 pregnant women who received a third (booster) dose of BNT162b2 vaccine.

Characteristic	Second Vaccination (n = 78)	Third Vaccination (n = 84)	p Value
Age	32.85 (± 3.49)	33.23(±3.95)	0.519
Mean gestational age at vaccine administration (weeks)	24.23 (±6.90)	21.02 (±9.69)	0.016
BMI	24.74 (±5.43)	23.41 (±4.137)	0.79
Autoimmune Disease	18 (23.1%)	14 (16.7%)	0.306
Lung Disease	2 (2.6%)	3 (3.6%)	0.711
Diabetes	2 (2.6%)	0 (0%)	0.14
Cardiovascular Disease	0 (0%)	3 (3.6%)	0.92

Data are given as mean ± SD or n (%). BMI, body mass index.